Get the Stockscreener App
2.42
5.10%
-0.13
After Hours:
2.35
-0.07
-2.89%
Annexon Inc stock is traded at $2.42, with a volume of 3.90M.
It is down -5.10% in the last 24 hours and down -0.82% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$2.55
Open:
$2.52
24h Volume:
3.90M
Relative Volume:
2.58
Market Cap:
$265.93M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.3672
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+11.52%
1M Performance:
-0.82%
6M Performance:
-9.02%
1Y Performance:
-64.04%
1-Day Range:
$2.41
$2.57
1-Week Range:
$2.10
$2.6975
52-Week Range:
$1.285
$7.85
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
2.42 | 251.64M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Is Annexon Inc. a candidate for recovery playShort Setup & Real-Time Volume Analysis Alerts - Newser
Annexon Inc. stock volume spike explainedChart Signals & Daily Market Momentum Tracking - Newser
Live market analysis of Annexon Inc.Global Markets & Community Shared Stock Ideas - Newser
Will Annexon Inc. see short term momentumInsider Selling & Consistent Profit Alerts - Newser
Sentiment analysis tools applied to Annexon Inc.Weekly Volume Report & Real-Time Volume Trigger Notifications - Newser
What MACD signals say about Annexon Inc.Jobs Report & Technical Pattern Based Buy Signals - Newser
Strategies to average down on Annexon Inc.2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Developing predictive dashboards with Annexon Inc. data2025 Trade Ideas & High Conviction Investment Ideas - Newser
How institutional ownership impacts Annexon Inc. stockJuly 2025 Reactions & Long-Term Growth Plans - Newser
Applying Wyckoff theory to Annexon Inc. stockEntry Point & AI Powered Buy/Sell Recommendations - Newser
Annexon Inc. stock outlook for YEARWeekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Applying chart zones and confluence areas to Annexon Inc.July 2025 Institutional & Smart Investment Allocation Tips - Newser
Will earnings trigger a reversal in Annexon Inc.Options Play & High Win Rate Trade Tips - Newser
Can Annexon Inc. rally from current levels2025 Key Lessons & High Accuracy Investment Signals - Newser
Analyzing recovery setups for Annexon Inc. investorsMarket Trend Review & Advanced Swing Trade Entry Alerts - Newser
Real time breakdown of Annexon Inc. stock performanceTrade Entry Summary & Community Verified Watchlist Alerts - Newser
How Annexon Inc. stock performs during market volatilityMarket Movement Recap & Expert Verified Movement Alerts - Newser
Combining price and volume data for Annexon Inc.Entry Point & High Conviction Buy Zone Picks - Newser
Earnings visualization tools for Annexon Inc.Weekly Gains Report & Expert Approved Trade Ideas - Newser
Long term hold vs stop loss in Annexon Inc.Earnings Miss & Low Drawdown Trading Techniques - Newser
Annexon Biosciences to Participate in Upcoming September Investor Conferences - Investing News Network
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 - Investing News Network
What technical models suggest about Annexon Inc.’s comeback2025 Big Picture & Reliable Intraday Trade Plans - Newser
Does Annexon Inc. fit your quant trading modelGlobal Markets & Stepwise Trade Execution Plans - Newser
Detecting price anomalies in Annexon Inc. with AIJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
How to build a dashboard for Annexon Inc. stockTrade Risk Report & Daily Price Action Insights - Newser
Backtesting results for Annexon Inc. trading strategiesTrade Signal Summary & Safe Investment Capital Preservation Plans - Newser
What machine learning models say about Annexon Inc.2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
Will Annexon Inc. benefit from macro trends2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
Will breakout in Annexon Inc. lead to full recoveryWeekly Market Outlook & Verified Swing Trading Watchlists - Newser
Analyzing Annexon Inc. with risk reward ratio chartsMarket Performance Report & Verified Stock Trade Ideas - Newser
Nuveen LLC Acquires Shares of 347,032 Annexon, Inc. $ANNX - MarketBeat
Price Action: Can Annexon Inc. reach all time highs this yearMarket Risk Report & Technical Confirmation Alerts - Lancaster City Council
Is Annexon Inc. stock risky to hold nowGap Up & Real-Time Buy Signal Notifications - beatles.ru
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Annexon (ANNX) Stock Price, News & Analysis - MarketBeat
Will Annexon Inc. benefit from current market trendsJuly 2025 Review & Risk Controlled Daily Plans - خودرو بانک
Can Annexon Inc. lead its sector in growthMarket Risk Summary & Real-Time Market Sentiment Reports - خودرو بانک
Forecasting Annexon Inc. price range with options dataOil Prices & Free Technical Confirmation Trade Alerts - Newser
What momentum shifts mean for Annexon Inc.Long Setup & Expert Verified Movement Alerts - Newser
Trading Action: Is Annexon Inc. benefiting from innovation trendsJuly 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Transcript : Annexon, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 03 - MarketScreener
Custom strategy builders for tracking Annexon Inc.2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Does Annexon Inc. offer margin of safetyPrice Action & Fast Momentum Stock Entry Tips - خودرو بانک
Is Annexon Inc. stock reversal real or fakeMarket Trend Review & Weekly Momentum Stock Picks - Newser
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):